Since the launch of the Office of New Drug Quality Assessment (ONDQA) CMC pilot program in July 2005, many QbD containing applications have been submitted, reviewed, and approved, both within and outside of the pilot. The objective of this presentation is to provide insight about the current state of QbD implementation as garnered from the QbD applications submitted to date. In addition, some remaining scientific and regulatory challenges will be discussed.&'
Would you like to access this content?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
You must be logged in to view this content. Log in now.
Purchase Technical Presentation
You must purchase this technical presentation using one of the options below.
If you already purchased this content recently, please click here to refresh the system's record of ownerships.
|Credits||0.5 Use credits|
|List Price||$25.00 Buy now|
|AIChE Members||$15.00 Buy now|
|AIChE Undergraduate Student Members||Free Free access|
|AIChE Graduate Student Members||$15.00 Buy now|